[A study of the mechanism of lidocaine and befol effects on Na-exchange in normal cardiomyocytes and in the experimental model of hypoxia in vitro].
Khankoeva
A I
AI
Galenko-Iaroshevskiĭ
P A
PA
Dukhanin
A S
AS
D000584:Amiloride / Q000031:analogs & derivatives / Q000494:pharmacology; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology*; D001549:Benzamides / Q000494:pharmacology*; D001572:Benzofurans; D015687:Cell Hypoxia / Q000187:drug effects; D002478:Cells, Cultured; D004791:Enzyme Inhibitors / Q000494:pharmacology; D006321:Heart / Q000187:drug effects*; D008012:Lidocaine / Q000494:pharmacology*; D009025:Morpholines / Q000494:pharmacology*; D009206:Myocardium / Q000166:cytology / Q000378:metabolism*; D010042:Ouabain / Q000494:pharmacology; D051381:Rats; D012964:Sodium / Q000378:metabolism*; D017923:Sodium-Hydrogen Exchangers / Q000378:metabolism; D000254:Sodium-Potassium-Exchanging ATPase / Q000037:antagonists & inhibitors / Q000378:metabolism; D013050:Spectrometry, Fluorescence
D000889:Anti-Arrhythmia Agents; D001549:Benzamides; D001572:Benzofurans; D004791:Enzyme Inhibitors; D009025:Morpholines; D017923:Sodium-Hydrogen Exchangers; D010042:Ouabain; D000584:Amiloride; C059049:befol; D008012:Lidocaine; D012964:Sodium; D000254:Sodium-Potassium-Exchanging ATPase; C105430:benzofuran; C039614:ethylisopropylamiloride